US Patent Issued to C4 THERAPEUTICS on April 21 for "C3-carbon linked glutarimide Degronimers for target protein degradation" (Colorado, Massachusetts Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,450, issued on April 21, was assigned to C4 THERAPEUTICS INC. (Watertown, Mass.).

"C3-carbon linked glutarimide Degronimers for target protein degradation" was invented by Andrew J. Phillips (Littleton, Colo.), Christopher G. Nasveschuk (Stoneham, Mass.), James A. Henderson (Weston, Mass.), Yanke Liang (Belmont, Mass.), Minsheng He (Andover, Mass.), Kiel Lazarski (Boston), Gesine Kerstin Veits (Somerville, Mass.) and Harit U. Vora (Andover, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention provides Degronimers that have carbon-linked E3 Ubiquitin Ligase targeting moieties (Degrons), which can be linked to a targeting ligand for a ...